The big takeaway for me was the two tranche structure. AGL to recover the prepayment through 9 PJ of gas, spread across the length of the contract. 2PJ is 5.17mmscfd...which will be Vali-1 and a tiny bit of Vali-3. The residual production can then all be sold into the higher priced tranche.
Logically you'd think that they'd be wanting to recover $15m plus interest, so likely a $2 discount from market price for the $9pj. I'd imagine that would be circa $8, but possibly higher.
Id imagine they'll produce at around 12mmscfd, so 5PJ per annum. 2pj at $8 and $3pj at 10....for $46m gross revenue. I can't see processing and other costs at any more than $4...and in that scenario would see net profit to the JV of $26m, or $6.5m net to MEL. $6.5m is around 0.6cps, which could sustain a 0.2cps dividend and leave $4.5m for operations. Juicy.
- Forums
- ASX - By Stock
- MEL
- Ann: Vali and Odin Update
MEL
metgasco ltd
Add to My Watchlist
0.00%
!
0.2¢

Ann: Vali and Odin Update, page-166
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.665M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $2.284K | 1.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 19005694 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 11409690 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 19005694 | 0.002 |
7 | 34000999 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 6059665 | 11 |
0.004 | 10479052 | 6 |
0.006 | 311675 | 1 |
0.020 | 15085 | 1 |
0.022 | 91666 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MEL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online